A Study to Assess Risk Stratification by Using Child-Pugh Score, Rate of Admission and Management Strategies of Inpatients with Alcoholic Liver Disease

  • Sunny Jaiswal Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India
  • Susmita Malakar Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India
  • Ajoy Mondal Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India
  • Dr. Geetha Jayaprakash Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India
DOI: https://doi.org/10.61280/tjpls.v13i4.305

Keywords:

Alcoholic Liver Disease, Child-Pugh Score, Risk Stratification, Portal Hypertension, Prescribing Patterns

Abstract

Objective: To assess risk stratification using the Child-Pugh scoring system, evaluate hospital admission profiles, and audit real-world pharmacological management in hospitalized patients with Alcoholic Liver Disease (ALD).

Methodology: A six-month prospective observational study included 123 confirmed ALD inpatients admitted to the General Medicine Department of ESIC Medical College & Model Hospital, Bengaluru. Demographic characteristics, alcohol consumption history, clinical features, laboratory parameters, and treatment patterns were recorded. Statistical analyses included Chi-square test, one-way ANOVA, Kruskal-Walli’s test, Spearman's rank correlation, and Odds Ratio (OR) analysis.

Results: The mean age was 47.30 ± 9.07 years, with 95.12% males. Most patients were classified as Child-Pugh Class C (58.54%), followed by Class B (29.26%) and Class A (12.20%). Alcohol consumption for >10 years was significantly associated with advanced liver disease (p = 0.0096; OR = 2.12). Disease severity was significantly associated with portal hypertension (79.67%, p < 0.001), ascites (65.85%, p < 0.001), hepatic encephalopathy (31.71%, p = 0.00017), hepatorenal syndrome (18.70%, p = 0.0222), coagulopathy (22.76%, p = 0.0216), and esophageal varices (49.60%, p = 0.0437). Laboratory abnormalities, including reduced albumin and elevated bilirubin, INR, AST, ALT, and ALP, correlated with increasing severity (p < 0.01). Although hospital stay did not differ significantly across Child-Pugh classes (p = 0.269), Class C patients had a twofold higher readmission risk (OR = 2.02). Lactulose, rifaximin, ursodeoxycholic acid, furosemide, and spironolactone were the most frequently prescribed drugs, while corticosteroid use was limited (3.25%).

Conclusion: The Child-Pugh score is an effective bedside tool for predicting disease severity, complications, and readmission risk in ALD. Variations from evidence-based treatment, particularly excessive ursodeoxycholic acid use and limited corticosteroid prescribing, highlight the need for improved guideline-directed management.

Downloads

Download data is not yet available.

Author Biographies

Sunny Jaiswal , Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India

Pharm D intern

Susmita Malakar , Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India

Pharm D intern

Ajoy Mondal , Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India

Pharm D intern

Dr. Geetha Jayaprakash , Department of Pharmacy Practice, Acharya & BM Reddy College of Pharmacy, Soladevanahalli, Hesaraghatta Main Road, Bengaluru – 560107, Karnataka, India

Associate Professor and Head

References

Rehm, J and Samokhvalov, AV (2013), "Global burden of alcoholic liver diseases", Lancet, Vol. 382 (9909), 1603-12.

Mackowiak, B; Fu, Y; Maccioni, L and Gao, B (2024), "Alcohol-associated liver disease", J Clin Invest, Vol. 134 (3), e176345.

World Health Organization (2018), “Global status report on alcohol and health 2018”, World Health Organization, Geneva.

Nand, N; Malhotra, P and Dhoot, DK (2015), "Clinical profile of alcoholic liver disease in a tertiary care centre", J Assoc Physicians India, Vol. 63 (6), 14-20.

Parate, T; Chavan, P and Parate, R (2022), "A clinical study of spectrum of liver diseases in alcoholic with respect to predictors of severity and prognosis", Vidarbha J Med, Vol. 32 (100), 100-7.

Tsoris, A and Marlar, CA (2025), "Use of the Child Pugh score in liver disease", In: StatPearls, StatPearls Publishing, Treasure Island.

Trifan, A et al. (2022), "Predictive factors for the prognosis of alcoholic liver cirrhosis", Medicina (Kaunas), Vol.

58 (12), 1859, Available in: http://dx.doi.org/10.3390/medicina58121859.

Hasan et al. (2023), "Child-Pugh Score of Decompensated Chronic Liver Disease Patient as a Predictor of Short-Term Prognosis", SAS J Med, Vol. 9 (2), 58-66.

Bruha, R (2012), "Alcoholic liver disease", World Journal of Hepatology, Vol. 4 (3), 81, Available in: https:// doi.org/10.4254/wjh.v4.i3.81.

Osna, NA; Donohue, TM Jr and Kharbanda, KK (2017), "Alcoholic liver disease: Pathogenesis and current management", Alcohol Research: Current Reviews, Vol. 38 (2), 147–161.

Abeysekera, KWM et al. (2022), "Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic review", Lancet Gastroenterol Hepatol, Vol. 7 (8), 770–80, Available in: http://dx.doi.org/10.1016/S2468-1253(22)00020-6.

Albers, I; Hartmann, H; Bircher, J and Creutzfeldt, W (1989), "Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis", Scandinavian Journal of Gastroenterology, Vol. 24 (3), 269–276, Available in: https://doi.org/10.3109/00365528909093045.

Cholongitas, E et al. (2005), "Systematic review: The model for end-stage liver disease--should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis?", Aliment Pharmacol Ther, Vol. 22 (11–12), 1079–89, Available in: http://dx.doi.org/10.1111/j.1365-2036.2005.02691.x.

Mylavarapu, M et al. (2022), “Comparison of the prognostic value of the Child–Pugh and MELD scoring systems in cirrhosis: A systematic review”, Journal of Clinical Critical and Emergency Medicine, 1–7, Available in: https://doi.org/10.47363/jccem/2022(1)115.

Verma, M; Gajraj, MS and Garg, M (2024), "A hospital based observational study to find out the causes of hospital mortality in patients admitted with decompensated cirrhosis of liver at tertiary care center", Int J Acad Med Pharm, Vol. 6 (2), 210–3.

Elzouki, AN et al. (2016), "Predicting mortality of patients with cirrhosis admitted to medical intensive care unit: An experience of a single tertiary center", Arab J Gastroenterol, Vol. 17 (4), 159–63, Available in: http:// dx.doi.org/10.1016/j.ajg.2016.11.003.

Baker, DIM et al. (2022), "Child-Pugh score of decompensated chronic Liver Disease patient as a predictor of short-term prognosis", SAS Journal of Medicine, Vol. 8 (2), 58–66, Available in: https://doi.org/10.36347/sasjm. 2022.v08i02.002.

Crabb, DW; Im, GY; Szabo, G; Mellinger, JL and Lucey, MR (2020), "Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases", Hepatology, Vol. 71 (1), 306–33, Available in: http://dx.doi.org/10.1002/hep.30866.

Jaiswal, P and Choubay, PP (2018), "Lipid profile V/s. Severity of Cirrhosis: A Child Pugh (CP) Score Based Study", PJSR, Vol. 2018 (1), 28–35.

Khan, H and Zarif, M (2006), "Risk factors, complications and prognosis of cirrhosis in a tertiary care hospital of Peshawar", Hepatis Monthly, Vol. 6 (1), 7–10.

Hasan, I; Nababan, SHH; Handayu, AD; Aprilicia, G and Gani, RA (2023), "Scoring system for predicting 90-day mortality of in-hospital liver cirrhosis patients at Cipto Mangunkusumo Hospital", BMC Gastroenterol, Vol. 23 (1), 190, Available in: http://dx.doi.org/10.1186/s12876-023-02813-4.

Hansen, L et al. (2022), "Symptom classes in decompensated liver disease", Clin Gastroenterol Hepatol, Vol. 20 (11), 2551-2557.e1, Available in: http://dx.doi.org/10.1016/j.cgh.2021.11.023.

S, Z; P, H; P, VSNE; T, K and P, L (2017), "A prospective observational study on prescribing patterns of drugs used in alcoholic liver disease patients at tertiary care teaching hospital", Int J Basic Clin Pharmacol, Vol. 6 (6), 1386, Available in: http://dx.doi.org/10.18203/2319-2003.ijbcp20172228.

Bertha, M; Choi, G and Mellinger, J (2021), "Diagnosis and treatment of alcohol-associated liver disease: A patient-friendly summary of the 2019 AASLD guidelines", Clin Liver Dis (Hoboken), Vol. 17 (6), 418–23, Available in: http://dx.doi.org/10.1002/cld.1129.

Cabezas, J (2022), "Management of alcohol-related liver disease and its complications", Clinical Drug Investigation, Vol. 42 (Suppl 1), 47–53, Available in: https://doi.org/10.1007/s40261-022-01143-9.

Patel, R and Mueller, M (2025), "Alcohol-associated liver disease", In: StatPearls, StatPearls Publishing, Treasure Island (FL).

Gramenzi, A; Caputo, F; Biselli, M; Kuria, F and Loggi, E (2006), "Review article: alcoholic liver disease - pathophysiological aspects and risk factors", Aliment Pharmacol Ther, Vol. 24 (8), 1151–61, Available in: http://dx.doi.org/10.1111/j.1365-2036.2006.03110.x.

Dugum, M and McCullough, A (2015), "Diagnosis and management of alcoholic liver disease", J Clin Transl Hepatol, Vol. 3 (2), 109–16, Available in: http://dx.doi.org/10.14218/JCTH.2015.00008.

Marsano, LS; Mendez, C; Hill, D; Barve, S and McClain, CJ (2003), "Diagnosis and treatment of alcoholic liver disease and its complications", Alcohol Res Health, Vol. 27 (3), 247–56.

Thursz, M and Lingford-Hughes, A (2023), "Advances in the understanding and management of alcohol-related liver disease", BMJ, Vol. 383, e077090, Available in: http://dx.doi.org/10.1136/bmj-2023-077090.

Kong, LZ et al. (2019), "Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease", Int J Mol Sci, Vol. 20 (11), 2712, Available in: http://dx.doi.org/10.3390/ijms20112712.

Anonymous (2024), “An Observational Descriptive Study on The Significance of Serum Zinc Levels in Hepatic Cirrhosis Patients and Its Correlation with Child - Pughs Score in A Tertiary Care Hospital”, Hospital European Journal of Cardiovascular Medicine, Vol. 14 (4), 1345–1351.

Tilg, H and Day, CP (2007), "Management strategies in alcoholic liver disease", Nat Clin Pract Gastroenterol Hepatol, Vol. 4 (1), 24–34, Available in: http://dx.doi.org/10.1038/ncpgasthep0683.

Yoon, EL and Kim, W (2023), "Current and future treatment for alcoholic-related liver diseases", J Gastroenterol Hepatol, Vol. 38 (8), 1218–26, Available in: http://dx.doi.org/10.1111/jgh.16257.

Sharma, P and Arora, A (2020), "Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis", Translational Gastroenterology and Hepatology, Vol. 5, 19, Available in: https://doi.org/10.21037/tgh.2019.10.02.

Torruellas, C (2014), "Diagnosis of alcoholic liver disease", World Journal of Gastroenterology: WJG, Vol. 20 (33), 11684, Available in: https://doi.org/10.3748/wjg.v20.i33.11684.

Awasthi, G and Shrestha, TM (2020), "Child Pugh score as a predictor of large esophageal varices in chronic liver disease patients", Nepal Medical Journal, Vol. 3 (1), 37–41.

Statistics
126 Views | 0 Downloads
Dimension Citations

Published

04-08-2026

How to Cite

Sunny Jaiswal, Susmita Malakar, Ajoy Mondal, and Dr. Geetha Jayaprakash. “A Study to Assess Risk Stratification by Using Child-Pugh Score, Rate of Admission and Management Strategies of Inpatients With Alcoholic Liver Disease”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 13, no. 4, Aug. 2026, doi:10.61280/tjpls.v13i4.305.

Issue

Section

Research Article